{"id":432811,"title":"Consultation on the Prescription Drug List: Naloxone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T08:55:46.842000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/prescription-drug-list-naloxone-consultation-notice.html","snippet":"Consultation on the Prescription Drug List: Naloxone The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to revise the qualifier for Naloxone on the Prescription Drug List (PDL). How to Get Involved This consultation is open for…","rawSnapshotUrl":"/api/snapshots/raw/432811","browseUrl":"https://replay.healtharchive.ca/job-6/20260102085546/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/prescription-drug-list-naloxone-consultation-notice.html#ha_snapshot=432811","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}